This poses a serious question for all of us working in HIV/AIDS-related projects across African countries. It is rare to find a clear policy on professional PEP, and even when policy is in place, its implementation is patchy to say the least. Health workers in program-supported facilities get exposed to possible infection, but data are scanty (no directory of professional incidents is being compiled); ARVs may not be easily available for any use other than treating registered patients; and a sense of resignation about the occurrence of these incidents is common among health staff. While the PEP strategy is being gradually expanded for post-rape survivors, it is paramount to provide it for health workers even in remote facilities with no ARV provision.
our programs should nonetheless endeavor to gather as much data on other aspects of care as possible and to find time for elaborating and analyzing more health information. This could produce two essential results. First, by doing so we should be able to look at the broader picture of our intervention as far as health care services are concerned. Secondly, we could be more informed and authoritative in documenting our findings, supporting our views, and contributing to the design of future programs.
Continuing the conversation about more effective use of the newer medications to improve efficacy and decrease toxicity in HIV patients.
The IAS-USA Treatment Guidelines were released during the conference, supporting earlier initiation of treatment with ART recommended for all patients with CD4 counts < 500, selected clinical conditions, and all symptomatic patients (provided patients are ready to start therapy: “The patient must be ready and willing to adhere to lifelong therapy,” the document explicitly states. Additional populations for ART initiation included pregnant women, and those with acute primary infections. The document is well worth a good read for its careful review of the data behind the pendulum swinging to earlier initiation in 2010.
President Clinton and Bill Gates Address International AIDS Conference
Bottom line: HIV probably does increase risk but not as much as some of the more traditional modifiable risk factors (like smoking). Hopefully, in the future the START study results whether treatment practices should be changed. .
Why are we blogging?
The JSI and WORLD EDUCATION CENTER for HIV and AIDS launched this blog as an effort to share more widely among our JSI and World Education staff worldwide, as well as external colleagues, reports from the XVIII International AIDS Conference in Vienna, Austria.
I’ve been fortunate to attend international HIV conferences for many years. Several of those conferences stand out in my memory for the results they produced. In Vancouver (1996), researchers first announced the results of the highly active antiretroviral therapy (HAART) clinical trials—changing the future for millions of us living with HIV. In Durban (2000), delegates … Continue reading “USAID IMPACT Blog: Mobile Clinics in India Take to the Road”